Perfil
Steve Colletti is currently the Chief Scientific Officer at Korro Bio, Inc. He previously worked as the SVP-Drug Discovery Research & Development at Zymergen, Inc. from 2021 to 2023.
Before that, he was the Chief Scientific Officer at Lodo Therapeutics Corp.
from 2018 to 2021.
Dr. Colletti holds a doctorate degree from Boston University and an undergraduate degree from Loyola University of Chicago.
Cargos activos de Steve Colletti
| Empresas | Cargo | Inicio |
|---|---|---|
Korro Bio, Inc.
Korro Bio, Inc. BiotechnologyHealth Technology Develops novel genetic medicines | Director Técnico/Científico/I+D | 01/02/2023 |
Antiguos cargos conocidos de Steve Colletti.
| Empresas | Cargo | Fin |
|---|---|---|
| ZYMERGEN INC. | Corporate Officer/Principal | 01/01/2023 |
Lodo Therapeutics Corp.
Lodo Therapeutics Corp. BiotechnologyHealth Technology Discovers and develops novel therapeutics | Director Técnico/Científico/I+D | 01/05/2021 |
Formación de Steve Colletti.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Boston University
Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Loyola University of Chicago
Loyola University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zymergen, Inc.
Zymergen, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that designs and develops genomics products | Health Technology |
Lodo Therapeutics Corp.
Lodo Therapeutics Corp. BiotechnologyHealth Technology Discovers and develops novel therapeutics | Health Technology |
Korro Bio, Inc.
Korro Bio, Inc. BiotechnologyHealth Technology Develops novel genetic medicines | Health Technology |
- Bolsa de valores
- Insiders
- Steve Colletti
















